Valuation: MindMaze Therapeutics Holding SA

Market Cap 25.26M 30.66M 27.46M 22.89M 42.78M 2.91B 43.59M 301M 121M 1.53B 115M 113M 4.83B P/E 2026 *
-2.25x
P/E 2027 * 2.97x
Enterprise Value 20.09M 24.38M 21.84M 18.2M 34.02M 2.31B 34.65M 240M 96.15M 1.22B 91.5M 89.55M 3.84B EV / Sales 2026 *
6.51x
EV / Sales 2027 * 0.62x
Free-Float
34.81%
Yield 2026 *
-
Yield 2027 * -
1 day-8.16%
1 week-7.12%
Current month+0.81%
1 month+0.81%
3 months-24.95%
6 months-53.71%
Current year-92.18%
1 week 0.15
Extreme 0.148
0.17
1 month 0.13
Extreme 0.1342
0.17
Current year 0.13
Extreme 0.1342
1.87
1 year 0.13
Extreme 0.1342
2.92
3 years 0.13
Extreme 0.1342
2.92
5 years 0.13
Extreme 0.1342
2.92
10 years 0.13
Extreme 0.1342
2.92
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/25 Sell 140,000 0.0908%
19/12/25 Sell 52,162 0.0338%
19/12/25 Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
-8.16%-7.12% - - 30.66M
-0.62%-1.87%+46.31%+56.99% 63.77B
+0.35%+3.20%+14.92%+84.55% 56.37B
+0.53%+1.96%+15.37%+106.81% 54.62B
-2.81%-4.31%+23.50%+50.90% 44.06B
-0.33%-1.93%+20.15%+98.45% 42.11B
+0.55%+2.31%+224.97%+942.56% 41B
+3.27%+47.96%+112.67%+96.48% 34.92B
+1.22%-1.44%+14.89%+47.15% 32.82B
+0.89%+20.55%-42.03%+373.03% 24.7B
Average -0.51%+6.07%+47.86%+206.32% 39.44B
Weighted average by Cap. +0.18%+5.44%+48.50%+186.13%

Financials

2026 *2027 *
Net sales 3.09M 3.75M 3.35M 2.8M 5.23M 356M 5.32M 36.8M 14.77M 187M 14.06M 13.76M 590M 28.23M 34.27M 30.69M 25.58M 47.82M 3.25B 48.71M 337M 135M 1.71B 129M 126M 5.4B
Net income -8.29M -10.06M -9.01M -7.51M -14.04M -955M -14.3M -98.86M -39.69M -503M -37.77M -36.96M -1.59B 10.38M 12.59M 11.28M 9.4M 17.57M 1.2B 17.9M 124M 49.67M 629M 47.26M 46.26M 1.98B
Net Debt -5.18M -6.28M -5.63M -4.69M -8.77M -597M -8.93M -61.72M -24.78M -314M -23.58M -23.08M -990M -7.65M -9.28M -8.32M -6.93M -12.96M -882M -13.2M -91.22M -36.62M -464M -34.85M -34.1M -1.46B
Projected Income Statement - Annual - MindMaze Therapeutics Holding SA
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
30/10/26 CHF 0.1486 -8.16% 606,680
29/10/26 CHF 0.1618 +3.72% 787,935
28/10/26 CHF 0.1560 -4.88% 1,248,036
27/10/26 CHF 0.1640 +3.67% 413,685
26/10/26 CHF 0.1582 -1.12% 309,158
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
MarketScreener Ratings - MindMaze Therapeutics Holding SA

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - MindMaze Therapeutics Holding SA